These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1207 related articles for article (PubMed ID: 8943686)

  • 1. 211At-methylene blue for targeted radiotherapy of disseminated melanoma: microscopic analysis of tumour versus normal tissue damage.
    Link EM; Michalowski AS; Rösch F
    Eur J Cancer; 1996 Oct; 32A(11):1986-94. PubMed ID: 8943686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [211At]methylene blue for targeted radiotherapy of human melanoma xenografts: dose fractionation in the treatment of cutaneous tumours.
    Link EM; Carpenter RN; Hansen G
    Eur J Cancer; 1996 Jun; 32A(7):1240-7. PubMed ID: 8758260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of cutaneous tumors and lymph node metastases.
    Link EM; Carpenter RN
    Cancer Res; 1992 Aug; 52(16):4385-90. PubMed ID: 1643635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 211At-methylene blue in targeted radiotherapy of disseminated melanoma.
    Link EM; Michalowski AS; Rösch F
    Pigment Cell Res; 1994 Oct; 7(5):358-62. PubMed ID: 7886009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of micrometastases.
    Link EM; Carpenter RN
    Cancer Res; 1990 May; 50(10):2963-7. PubMed ID: 2334899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake and therapeutic effectiveness of 125I- and 211At-methylene blue for pigmented melanoma in an animal model system.
    Link EM; Brown I; Carpenter RN; Mitchell JS
    Cancer Res; 1989 Aug; 49(15):4332-7. PubMed ID: 2743321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting disseminated melanoma with radiolabelled methylene blue: Comparative bio-distribution studies in man and animals.
    Link EM; Costa DC; Lui D; Ell PJ; Blower PJ; Spittle MF
    Acta Oncol; 1996; 35(3):331-41. PubMed ID: 8679265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting melanoma with 211At/131I-methylene blue: preclinical and clinical experience.
    Link EM
    Hybridoma; 1999 Feb; 18(1):77-82. PubMed ID: 10211792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
    Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
    J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18.
    Andersson H; Lindegren S; Back T; Jacobsson L; Leser G; Horvath G
    Anticancer Res; 2000; 20(1A):459-62. PubMed ID: 10769696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astatine-211-labeled radiotherapeutics: an emerging approach to targeted alpha-particle radiotherapy.
    Zalutsky MR; Vaidyanathan G
    Curr Pharm Des; 2000 Sep; 6(14):1433-55. PubMed ID: 10903402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-melanoma efficacy of internal radionuclide therapy in relation to melanin target distribution.
    Bonnet M; Mishellany F; Papon J; Cayre A; Penault-Llorca F; Madelmont JC; Miot-Noirault E; Chezal JM; Moins N
    Pigment Cell Melanoma Res; 2010 Oct; 23(5):e1-11. PubMed ID: 20444199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the therapeutic efficacy of 211At- and 131I-labelled monoclonal antibody MOv18 in nude mice with intraperitoneal growth of human ovarian cancer.
    Andersson H; Palm S; Lindegren S; Bäck T; Jacobsson L; Leser G; Horvath G
    Anticancer Res; 2001; 21(1A):409-12. PubMed ID: 11299770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumour injection of immunoglobulins labelled with the alpha-particle emitter 211At: analyses of tumour retention, microdistribution and growth delay.
    Larsen RH; Bruland OS
    Br J Cancer; 1998 Apr; 77(7):1115-22. PubMed ID: 9569048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous 211At alpha-particle radiotherapy for undifferentiated thyroid cancer.
    Brown I; Carpenter RN
    Acta Radiol Suppl; 1991; 376():174-5. PubMed ID: 1666771
    [No Abstract]   [Full Text] [Related]  

  • 16. The development of a [211AT]-astatinated endoradiotherapeutic drug: part IV--late radiation effects.
    Brown I; Mitchell JS
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1177-83. PubMed ID: 9539575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted radiotherapy of pigmented melanoma with
    Xu X; Yuan L; Gai Y; Liu Q; Yin L; Jiang Y; Wang Y; Zhang Y; Lan X
    J Exp Clin Cancer Res; 2018 Dec; 37(1):306. PubMed ID: 30537980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The curative and palliative potential of the monoclonal antibody MOv18 labelled with 211At in nude mice with intraperitoneally growing ovarian cancer xenografts--a long-term study.
    Andersson H; Lindegren S; Bäck T; Jacobsson L; Leser G; Horvath G
    Acta Oncol; 2000; 39(6):741-5. PubMed ID: 11130014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histopathological study of subcutaneous heterograft of human gastric cancer in nude mice treated with 211At labelled monoclonal antibody].
    Luo DY
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):23-5. PubMed ID: 8334936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of melanoma metastases with radioiodinated methylene blue.
    Link EM; Blower PJ; Costa DC; Lane DM; Lui D; Brown RS; Ell PJ; Spittle MF
    Eur J Nucl Med; 1998 Sep; 25(9):1322-9. PubMed ID: 9724383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.